Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2019-02-27 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections regarding the 'Notification of Major Holdings' as per German Securities Trading Act (WpHG) requirements. It details changes in voting rights percentages held by FMR LLC and its subsidiaries, crossing specific thresholds (Section 6 and 7). This directly corresponds to the definition of reporting changes in significant share ownership levels, which aligns best with the Major Shareholding Notification (MRQ) code. Although the header mentions 'Voting Rights Announcements', the content structure is a formal notification of a change in holding percentage, which is the core function of an MRQ filing.
2019-02-27 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German securities law (WpHG). It details the acquisition/disposal of shares with voting rights by Schroders plc, crossing a threshold on February 22, 2019. This directly corresponds to the definition of a major shareholding notification, which is classified under the code MRQ (Major Shareholding Notification). Although the header mentions 'Voting Rights Announcements', the content structure is a standard major holding disclosure.
2019-02-27 English
MorphoSys to Present at Upcoming Investor Conference
Regulatory Filings Classification · 99% confidence The document is a short news release dated February 21, 2019, announcing that MorphoSys AG will present at the '8th Annual Leerink Partners Global Healthcare Conference' on February 28, 2019. It provides details about the conference, the presenters, and links to where presentation PDFs and webcasts will be available. This is not a full financial report (like 10-K or IR), nor is it a formal regulatory filing like an earnings release (ER) or a major shareholder notification (MRQ). It is an announcement about participation in an investor event, which aligns best with an Investor Presentation (IP) announcement or, given its nature as a general corporate news item about investor relations activities, it could be classified as a Regulatory Filing (RNS) if a more specific category doesn't fit perfectly. However, since it explicitly details an upcoming presentation where investor materials will be shared, 'Investor Presentation' (IP) is the most relevant category, even though it's an announcement *about* the presentation rather than the presentation itself. Given the options, and recognizing this is a standard IR communication about an upcoming event where an IP will be given, IP is the strongest fit over the general RNS fallback.
2019-02-21 English
Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire (news with additional features)
Board/Management Information Classification · 100% confidence The document is a formal announcement dated February 19, 2019, titled "Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire." It details the decision of the CEO not to renew his contract and his planned departure date. This content directly relates to changes in senior management personnel. This aligns perfectly with the definition for Board/Management Information (MANG). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific management event.
2019-02-19 English
Ad hoc: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire
Board/Management Information Classification · 100% confidence The document is an 'Ad hoc' announcement dated February 19, 2019, disclosing that the CEO and Co-Founder, Simon Moroney, intends to retire and step down on June 30, 2020. This content directly relates to a change in senior management/board composition. This aligns perfectly with the definition for Board/Management Information (MANG). It is not an earnings release (ER), a full annual report (10-K), or a proxy statement (DEF 14A/PSI).
2019-02-19 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It reports a change in the percentage of voting rights held by Invesco Ltd. (crossing the 3% threshold). This directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ' in the provided schema, even though the document header mentions 'Voting Rights Announcements' which might suggest DVA, the content is specifically about crossing a major holding threshold (3.03%), which aligns best with MRQ.
2019-02-14 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.